BG31073A3 - Method for obtaining of 1, 5- substituated- 2- pyrolidine - Google Patents

Method for obtaining of 1, 5- substituated- 2- pyrolidine

Info

Publication number
BG31073A3
BG31073A3 BG037109A BG3710977A BG31073A3 BG 31073 A3 BG31073 A3 BG 31073A3 BG 037109 A BG037109 A BG 037109A BG 3710977 A BG3710977 A BG 3710977A BG 31073 A3 BG31073 A3 BG 31073A3
Authority
BG
Bulgaria
Prior art keywords
substituated
pyrolidine
obtaining
pyrrolidones
disubstituted
Prior art date
Application number
BG037109A
Other languages
Bulgarian (bg)
English (en)
Inventor
Albin Nelson
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG31073A3 publication Critical patent/BG31073A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG037109A 1976-08-06 1977-08-05 Method for obtaining of 1, 5- substituated- 2- pyrolidine BG31073A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
BG31073A3 true BG31073A3 (en) 1981-10-15

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
BG037109A BG31073A3 (en) 1976-08-06 1977-08-05 Method for obtaining of 1, 5- substituated- 2- pyrolidine

Country Status (31)

Country Link
JP (2) JPS5321159A (de)
AR (1) AR217080A1 (de)
AT (1) AT362887B (de)
AU (1) AU508007B2 (de)
BE (1) BE857506A (de)
BG (1) BG31073A3 (de)
CA (1) CA1077948A (de)
CH (1) CH624934A5 (de)
CS (1) CS221269B2 (de)
DD (2) DD143768A5 (de)
DE (1) DE2735904A1 (de)
DK (1) DK352077A (de)
ES (2) ES461388A1 (de)
FI (1) FI70009C (de)
FR (1) FR2369260A1 (de)
GB (2) GB1556569A (de)
GR (1) GR68688B (de)
HU (1) HU180273B (de)
IE (1) IE45505B1 (de)
IL (1) IL52615A (de)
LU (1) LU77936A1 (de)
NL (1) NL7708637A (de)
NO (1) NO772752L (de)
NZ (1) NZ184806A (de)
PH (1) PH17398A (de)
PL (2) PL200124A1 (de)
PT (1) PT66891B (de)
SE (1) SE423813B (de)
SU (3) SU703016A3 (de)
YU (1) YU192577A (de)
ZA (1) ZA774704B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
PT1132086E (pt) 2000-01-31 2006-09-29 Pfizer Prod Inc Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
EP1339678B1 (de) * 2000-11-27 2007-09-26 Pfizer Products Inc. Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose
IL159996A0 (en) * 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
ES2268327T3 (es) * 2002-03-18 2007-03-16 Pfizer Products Inc. Uso de un selectivo de un receptor de ep4 para el tratamiento de enfermedades.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PL200124A1 (pl) 1978-05-22
JPS585196B2 (ja) 1983-01-29
FI70009B (fi) 1986-01-31
SE7708642L (sv) 1978-02-07
NZ184806A (en) 1980-04-28
NL7708637A (nl) 1978-02-08
IL52615A (en) 1981-09-13
AT362887B (de) 1981-06-25
AU508007B2 (en) 1980-03-06
PT66891B (en) 1979-01-26
IE45505L (en) 1978-02-06
JPS5555161A (en) 1980-04-22
CH624934A5 (de) 1981-08-31
AU2751577A (en) 1979-02-08
GB1556570A (en) 1979-11-28
LU77936A1 (de) 1978-04-27
PT66891A (en) 1977-09-01
FR2369260A1 (fr) 1978-05-26
SE423813B (sv) 1982-06-07
GR68688B (de) 1982-02-01
ATA579477A (de) 1980-11-15
DE2735904A1 (de) 1978-02-09
HU180273B (en) 1983-02-28
GB1556569A (en) 1979-11-28
JPS5321159A (en) 1978-02-27
NO772752L (no) 1978-02-07
JPS5531147B2 (de) 1980-08-15
ZA774704B (en) 1978-06-28
PH17398A (en) 1984-08-08
DD136135A5 (de) 1979-06-20
ES471349A1 (es) 1979-09-16
IL52615A0 (en) 1977-10-31
SU818480A3 (ru) 1981-03-30
BE857506A (fr) 1978-02-06
CS221269B2 (en) 1983-04-29
PL112931B1 (en) 1980-11-29
SU703016A3 (ru) 1979-12-05
ES461388A1 (es) 1978-12-01
FR2369260B1 (de) 1982-02-12
DK352077A (da) 1978-02-07
DD143768A5 (de) 1980-09-10
AR217080A1 (es) 1980-02-29
FI70009C (fi) 1986-09-12
YU192577A (en) 1983-04-30
CA1077948A (en) 1980-05-20
FI772376A (de) 1978-02-07
IE45505B1 (en) 1982-09-08
SU850000A3 (ru) 1981-07-23

Similar Documents

Publication Publication Date Title
BG33286A3 (en) Method for obtaining of 4- hydroxy- 2h- 1, 2- benzothiazin- 3- carboxamid- 1, 1- dioxides
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG31497A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31225A3 (en) Method for obtaining of acilanilid derivatives
BG31645A3 (en) Method for obtaining of phenetanolamine
BG34338A3 (en) Method for obtaining thiadiazolylcephalosporines
BG30019A3 (en) Method for obtaining of three substituated 1- phenyl- 2,3,4,5- tetrahydro- 1h- 3- benzazepines
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG33294A3 (en) Method for obtaining the derivatives of 4- dezacetyl- vincaledcoblactine c- 3- carboxyhydrazid
BG29722A3 (en) Method for obtaining of 2, 5- disubstituated pyrimidin- 4- on
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG30021A3 (en) Method for obtaining of imidazoisohinolin- dion
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG28574A3 (en) Method of obtaining of 4- diphenylmethylene- 1- hydroxybensylpiperidin
BG30475A3 (en) Method for obtaining of deposteroid esters
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28415A4 (en) Method of obtaining of 9-hydroxyoctahydrobenzo (c) hynolines
BG32117A4 (en) Method for obtaining of oleandomicine
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG33283A3 (en) Method for obtaining of pyridazinylhydrazon
BG31947A3 (en) Method for obtaining of acetidine derivatives
BG28062A3 (en) Method of obtaining of 6a,10a, cishexahydrodibenzopyranones
BG29285A3 (en) Method of obtaining of 3- di- n- propyl- acetoxy- benzodiazepin- 2- on